Abstract
BackgroundMutations in bone morphogenetic protein receptor II (BMPR-II) have been shown to underlie most heritable cases of Pulmonary arterial hypertension (PAH). However, less than half the individuals who harbour mutations...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
